Minerva Surgical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Darrin Hammers
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Is There An Opportunity With Minerva Surgical, Inc.'s (NASDAQ:UTRS) 44% Undervaluation?
Aug 11
Minerva downgraded at JPMorgan citing lowered guidance
Aug 10Minerva Surgical, Inc. (NASDAQ:UTRS) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 10Minerva Surgical - Uterine Play For Sale
Nov 02CEO
Darrin Hammers
less than a year
Tenure
Mr. Darrin Hammers is Chief Executive Officer of Minerva Surgical, Inc. from August 2024. He has certain years of leadership experience in the medical device industry and he has been President and Chief Ex...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | no data | no data | |
| Vice President of Finance | less than a year | no data | no data | |
| Vice President of Sales | less than a year | no data | no data | |
| Vice President of Human Resources | no data | no data | no data | |
| Chief Medical Officer | 1.9yrs | US$388.99k | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| Vice President of Corporate Controller | 3.8yrs | no data | no data |
0.9yrs
Average Tenure
Experienced Management: UTRS's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 1.8yrs | no data | no data | |
| Independent Director | 3.8yrs | US$187.50k | 0.067% $ 0.005 | |
| Independent Director | 1.8yrs | no data | 0% $ 0 |
1.8yrs
Average Tenure
56yo
Average Age
Experienced Board: UTRS's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 15:07 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Minerva Surgical, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Marcus | J.P. Morgan |
| Danielle Antalffy | Leerink Partners LLC |
| Matthew O'Brien | Piper Sandler Companies |